全文获取类型
收费全文 | 258篇 |
免费 | 8篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 19篇 |
妇产科学 | 1篇 |
基础医学 | 33篇 |
口腔科学 | 11篇 |
临床医学 | 32篇 |
内科学 | 10篇 |
皮肤病学 | 6篇 |
神经病学 | 4篇 |
特种医学 | 1篇 |
外科学 | 3篇 |
综合类 | 9篇 |
预防医学 | 18篇 |
药学 | 110篇 |
中国医学 | 10篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 4篇 |
2022年 | 8篇 |
2021年 | 3篇 |
2020年 | 2篇 |
2019年 | 11篇 |
2018年 | 10篇 |
2017年 | 5篇 |
2016年 | 5篇 |
2015年 | 5篇 |
2014年 | 17篇 |
2013年 | 18篇 |
2012年 | 11篇 |
2011年 | 12篇 |
2010年 | 13篇 |
2009年 | 16篇 |
2008年 | 18篇 |
2007年 | 18篇 |
2006年 | 9篇 |
2005年 | 8篇 |
2004年 | 4篇 |
2003年 | 6篇 |
2002年 | 9篇 |
2001年 | 8篇 |
2000年 | 5篇 |
1999年 | 7篇 |
1998年 | 4篇 |
1997年 | 8篇 |
1996年 | 10篇 |
1993年 | 4篇 |
1992年 | 1篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有268条查询结果,搜索用时 31 毫秒
1.
Mariko Morimoto 《Health marketing quarterly》2020,37(2):108-123
AbstractThis research explores how the level of consumers’ need for cognition (NFC) is associated with celebrity endorser credibility and examines its effects on advertising-related attitudes. A 3 (endorser types: actor/actress, athlete, TV personality/talent) × 2 (endorser’s gender) factorial experiment with 435 Japanese consumers was conducted. Concerning Japanese OTC drug advertising, lower NFC individuals perceived celebrity endorsers as more credible in comparison to higher NFC individuals. The main effects of NFC and endorser type on endorser credibility existed; however, no interaction between the two variables was found. The endorser type had an influence on attitudes toward ads and the advertised brand. 相似文献
2.
OTC药评审的法律依据和程序 总被引:1,自引:0,他引:1
处方药和非处方药(Rx&OTC)分类管理制度是由国家法律强制作推行的药品管理制度,药品,制剂或活性成分的OTC身分也是根据有关法规,履行法定的审批程序而确立的,我国正在酝酿的Rx&OTC分类管理制度对公众甚至医学从业人员都是陌生的新事物,在必要通过介绍国外现行该制度是国家的做法,了解有关OTC药的立法及药品确立OTC身分的合法程序,作为我国将出台的Rx&OTC分类管理制度的借鉴。 相似文献
3.
4.
OTC市场已成为制药企业获得经济收益的重要市场之一.由于OTC是一种特殊的消费品,因此广告策略在营销过程中起着举足轻重的作用.合理运用广告策略,是制药企业在这一市场获得成功的关键. 相似文献
5.
6.
目的 对日本医疗用汉方医药品和一般用汉方医药品市场占有率最大的企业日本津村制药公司和Kracie制药公司2008-2020年间申请的专利内容进行综述,为国内中药经典名方和保健食品研发、知识产权保护提供参考。方法 通过日本专利局的官方检索渠道J-PlatPat平台,检索日本津村制药公司和Kracie制药公司在2008年至2020年间申请的专利,并进行专利布局和技术内容分析。结果 共收集43项日本津村制药公司特许和实用新案专利,其围绕汉方制剂产品全过程质量控制构建了坚实的专利技术体系;共收集52项Kracie制药公司特许和实用新案专利,其致力于功能性制剂和组合物的开发,重点在生活改善、老龄化和癌症等领域进行专利布局,还创建了多种产品功效和功能的客观评价方法。结论 津村制药近十年专利布局提示在中药现代化制造和走向国际的过程中,应把提高品质作为主攻方向,树立持续质量改进理念,完善产品有效性证据链。Kracie制药公司践行的以人为中心的汉方药设计理念,以及精准满足消费者健康需求的研发模式值得借鉴。 相似文献
7.
Halis Kaan Akturk Ana Maria Chindris Jolaine M. Hines Ravinder J. Singh Victor J. Bernet 《Mayo Clinic proceedings. Mayo Clinic》2018,93(3):284-290
Objective
To assess whether dietary supplements that are herbal and/or animal-derived products, marketed for enhancing metabolism or promoting energy, “adrenal fatigue,” or “adrenal support,” contain thyroid or steroid hormones.Methods
Twelve dietary adrenal support supplements were purchased. Pregnenolone, androstenedione, 17-hydroxyprogesterone, cortisol, cortisone, dehydroepiandrosterone sulfate, synthetic glucocorticoids (betamethasone, dexamethasone, fludrocortisone, megestrol acetate, methylprednisolone, prednisolone, prednisone, budesonide, and triamcinolone acetonide) levels were measured twice in samples in a blinded fashion. This study was conducted between February 1, 2016, and November 1, 2016.Results
Among steroids, pregnenolone was the most common hormone in the samples. Budesonide, 17-hydroxyprogesterone, androstenedione, cortisol, and cortisone were the others in order of prevalence. All the supplements revealed a detectable amount of triiodothyronine (T3) (63-394.9?ng/tablet), 42% contained pregnenolone (66.12-205.2?ng/tablet), 25% contained budesonide (119.5-610 ng/tablet), 17% contained androstenedione (1.27-7.25 ng/tablet), 8% contained 17-OH progesterone (30.09 ng/tablet), 8% contained cortisone (79.66 ng/tablet), and 8% contained cortisol (138.5 ng/tablet). Per label recommended doses daily exposure was up to 1322 ng for T3, 1231.2 ng for pregnenolone, 1276.4 ng for budesonide, 29 ng for androstenedione, 60.18 ng for 17-OH progesterone, 277 ng for cortisol, and 159.32 ng for cortisone.Conclusion
All the supplements studied contained a small amount of thyroid hormone and most contained at least 1 steroid hormone. This is the first study that measured thyroid and steroid hormones in over-the-counter dietary “adrenal support” supplements in the United States. These results may highlight potential risks of hidden ingredients in unregulated supplements. 相似文献8.
Paul A. Moore 《Journal of the American Dental Association (1939)》2013,144(8):898-908
BackgroundEffective and safe drug therapy for the management of acute postoperative pain has relied on orally administered analgesics such as ibuprofen, naproxen and acetaminophen, or N-acetyl-p-aminophenol (APAP), as well as combination formulations containing opioids such as hydrocodone with APAP. The combination of ibuprofen and APAP has been advocated in the last few years as an alternative therapy for postoperative pain management. The authors conducted a critical analysis to evaluate the scientific evidence for using the ibuprofen-APAP combination and propose clinical treatment recommendations for its use in managing acute postoperative pain in dentistry.Types of Studies ReviewedThe authors used quantitative evidence-based reviews published by the Cochrane Collaboration to determine the relative analgesic efficacy and safety of combining ibuprofen and APAP. They found additional articles by searching the Ovid MEDLINE, PubMed and http://ClinicalTrials.gov databases.ConclusionsThe results of the quantitative systematic reviews indicated that the ibuprofen-APAP combination may be a more effective analgesic, with fewer untoward effects, than are many of the currently available opioid-containing formulations. In addition, the authors found several randomized controlled trials that also indicated that the ibuprofen-APAP combination provided greater pain relief than did ibuprofen or APAP alone after third-molar extractions. The adverse effects associated with the combination were similar to those of the individual component drugs.Practical ImplicationsCombining ibuprofen with APAP provides dentists with an additional therapeutic strategy for managing acute postoperative dental pain. This combination has been reported to provide greater analgesia without significantly increasing the adverse effects that often are associated with opioid-containing analgesic combinations. When making stepwise recommendations for the management of acute postoperative dental pain, dentists should consider including ibuprofen-APAP combination therapy. 相似文献
9.
10.